CMA Sues CFTC, seeking to overturn approval for single-stock perpetual contracts
BIBIBI
AT A GLANCE
Cboe joins CMA in suing CFTC, seeking to overturn approval for perpetual derivatives on individual U.S. stocks and stay its effectiveness.
Article
Cboe, Citadel Securities and others sue CFTC, seeking to overturn approval for single-stock perpetual contracts
PANews November 4 reported, according to an official Cboe announcement, that the Chicago Board Options Exchange (Cboe) has joined the industry organization Capital Markets Alliance (CMA) in its lawsuit against the U.S. Commodity Futures Trading Commission (CFTC), challenging CFTC's approval of perpetual derivatives on individual U.S. stocks.CMA Members include Cboe, Citadel Securities, and the Healthy Markets Association.CMA has filed suit in the U.S. District Court for the Southern District of New York, seeking to overturn the relevant approval, have such products ruled to be security-based swaps, and prevent the approval from taking effect during the litigation. According to The Defiant, the challenged approval involves Coinbase, Kals...
PANews stated that Cboe has joined the Capital Markets Alliance (CMA) in a lawsuit against CFTC.
02
The lawsuit challenges CFTC's approval of perpetual derivatives on individual U.S. stocks.
03
CMA Members include Cboe, Citadel Securities, and the Healthy Markets Association.
04
CMA has filed suit in the U.S. District Court for the Southern District of New York.
05
CMA It seeks to overturn the relevant approval and have such products ruled to be security-based swaps.
06
CMA It also seeks to prevent the relevant approval from taking effect during the litigation.
07
According to The Defiant, the challenged approval involves Coinbase; the remainder of the list was truncated in the original text.
AI-assisted interpretation
The following is analysis, separate from reported facts. Verify important claims independently.
Perpetual derivatives generally have no fixed expiration date, and their value tracks changes in the underlying asset. The central dispute in this case is how perpetual products on individual U.S. stocks should be classified and regulated.CMA seeks to have the court overturn CFTC's relevant approval and first prevent the approval from taking effect while the case is being heard.
Why it matters to readers
The lawsuit directly challenges the regulatory approval of the relevant products. Whether the court grants the requests to overturn and stay the approval may affect whether these products can proceed under that approval.
Beginners should understand this as a judicial challenge to a regulatory approval, not that the approval has already been overturned or that the court has already ruled the products to be security-based swaps.
Risks and unknowns
The evidence does not indicate whether the court has accepted the case, issued a preliminary injunction, or rendered a final ruling.
The end of the main text was truncated, making it impossible to confirm all platforms and the scope of products involved.
The evidence does not provide CFTC, Coinbase, or any other parties involved.
“Constitutes a securities-based swap” is a litigation claim and cannot yet be regarded as a court conclusion.
Related Developments
Loading event timeline…
Related concepts
Perpetual derivatives
This term is not in the glossary yet. Browse related concepts in the glossary.
